Recovery Rate in Secondary Hypothyroidism

Launched by NOVA SCOTIA HEALTH AUTHORITY · Mar 9, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how well patients with secondary hypothyroidism, a condition where the body doesn’t produce enough thyroid hormone due to a problem with the pituitary gland, can recover when they receive treatment. The researchers want to find out how effective the current treatment, which involves taking a medication called T4, is for helping these patients get better.

To join this trial, participants need to be between the ages of 65 and 74 and must have a confirmed diagnosis of secondary hypothyroidism while currently taking T4 replacement therapy. However, people with uncontrolled heart problems, severe mental health issues, or those who are not properly treated and still have low T4 hormone levels cannot participate. If someone is eligible and decides to join, they will be monitored closely throughout the study to see how well their condition improves. This trial is currently recruiting participants, so there is an opportunity for those who qualify to contribute to important research in this area.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Confirmed diagnosis of secondary hypothyroidism who are currently taking T4 replacement therapy
• Exclusion Criteria:
• • uncontrolled cardiovascular disease
• • uncontrolled congestive heart failure
• • uncontrolled mental health disorder
• • not adequately replaced and have low T4 level.